Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Promote Your Event
Submission Forms
Place an Ad
Weather
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Items For Sale
Jobs
Pets
Auctions, Estate & Garage Sales
Place an ad
Services
Community
Personals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Ultragenyx Pharmaceutical Inc.
Ultragenyx to Present at Guggenheim’s Genomic Medicines and Rare Disease Days
March 28, 2023
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 21, 2023
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President
March 14, 2023
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Ultragenyx to Participate in Orphan Neuro Panel at Cowen Healthcare Conference
February 28, 2023
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Ultragenyx Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
February 16, 2023
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2022 Financial Results and Corporate Update
February 09, 2023
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Ultragenyx Reports Preliminary 2022 Revenue; Guidance for 2023 Revenue and Cash Usage; Pipeline Updates and 2023 Milestones
January 06, 2023
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Ultragenyx to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 21, 2022
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Ultragenyx to Present at Piper Sandler Healthcare Conference
November 22, 2022
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 18, 2022
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Ultragenyx Announces Departure of Chief Financial Officer
November 10, 2022
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Ultragenyx to Present at Upcoming Healthcare Conferences
November 09, 2022
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Ultragenyx Reports Third Quarter 2022 Financial Results and Corporate Update
November 02, 2022
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Ultragenyx to Host Conference Call for Third Quarter 2022 Financial Results and Corporate Update
October 27, 2022
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 04, 2022
From
Ultragenyx Pharmaceutical Inc.
Via
Globe NewsWire
Tickers
RARE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.